BUZZ-Quest Diagnostics shares rise after upbeat 2026 forecast** Shares of laboratory operator Quest Diagnostics DGX.N were up 1.57% at $194.25 premarket
** Co forecasts 2026 revenue in the range of $11.7 billion to $11.82 billion, above analysts' estimates of $11.39 billion, according to data compiled by LSEG
** Co forecasts 2026 adj profit between $10.50 and $10.70 per share, compared to estimates of $10.43 per share
** Q4 revenue rose 7.1% to $2.81 billion, beating estimates of $2.75 billion
** Co reported Q4 adj profit/shr of $2.42, vs estimates of $2.36
** DGX stock was up 15% in 2025
(Reporting by Gnaneshwar Rajan in Bengaluru)
((Gnaneshwar.Rajan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.